A Plant-Based Solution for Sustainable Biopharma

Kiah Bio is redefining Australia’s biopharmaceutical landscape through a pioneering plant‑based platform powered by advanced vertical hydroponic cultivation. By combining a high-protein-yielding plant variety with proprietary platform technology and an intensive vertical farming system, we deliver rapid, scalable, and cost-effective development of biopharmaceutical peptides. These peptides can find applications in essential therapeutics, such as insulin, vaccines, enzymes, antibodies, and biosimilars, making them more accessible and affordable for Australia and global markets.